Evaluation status available after sign-in
About the journal
eJHaem is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,150 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Wiley
- ISSN
- 2688-6146
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,150 USD
- Articles in DOAJ
- 1414
- Declared review time
- 8 weeks
- Declared peer-review model
- other
- Official website
- https://onlinelibrary.wiley.com/journal/26886146
Index listings
- DOAJ · 2023-08-17
- Indexing
- DOAJ
- APC
- 3,150 USD
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1414
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
1451
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
23
i10-index
128
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2023-08-17
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 91%
- ORCID iDs in current deposits
- 70%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- EJHaemeJournal of Haematology
- Source type
- journal
- NLM unique ID (PubMed)
- 101761942
- Society affiliations
- British Society for Haematology
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
LCC codes
RC633-647.5
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
Show all subjects (75)
- Multiple Myeloma Research and Treatments
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Multiple Myeloma Research and Treatments
- Hemoglobinopathies and Related Disorders
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Lymphoblastic Leukemia research
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Viral-associated cancers and disorders
- Hematological disorders and diagnostics
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Retinoids in leukemia and cellular processes
- CAR-T cell therapy research
- CAR-T cell therapy research
- Platelet Disorders and Treatments
- Blood groups and transfusion
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Blood groups and transfusion
- CNS Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- CNS Lymphoma Diagnosis and Treatment
- Platelet Disorders and Treatments
- CNS Lymphoma Diagnosis and Treatment
- Platelet Disorders and Treatments
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Blood groups and transfusion
- Chronic Myeloid Leukemia Treatments
- Iron Metabolism and Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Iron Metabolism and Disorders
- Immunodeficiency and Autoimmune Disorders
- COVID-19 Clinical Research Studies
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Cutaneous lymphoproliferative disorders research
- Complement system in diseases
- Eosinophilic Disorders and Syndromes
- Cutaneous lymphoproliferative disorders research
- Cutaneous lymphoproliferative disorders research
- Eosinophilic Disorders and Syndromes
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Blood disorders and treatments
- Blood disorders and treatments
- Complement system in diseases
- Complement system in diseases
- Blood disorders and treatments
- Blood transfusion and management
- Erythrocyte Function and Pathophysiology
- Erythrocyte Function and Pathophysiology
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
- COVID-19 Clinical Research Studies
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Monoclonal and Polyclonal Antibodies Research
- COVID-19 Clinical Research Studies
Keywords (DOAJ)
- haematology
- epidemiology
- plasma cells
- blood diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ